Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA B R Antibodies

Rada A., Hagemann A., Aaberg Poulsen C., Baumgartner T., Berki T., Blaabjerg M., Brenner J., Britton JW., Christiana A., Ciano-Petersen NL., Crijnen Y., Elišák M., Farina A., Friedman AR., Hayden Z., Hébert J., Holtkamp M., Hong Z., Honnorat J., Ilyas-Feldmann M., Irani SR., Kovac S., Marusic P., Muñiz-Castrillo S., Ramanathan S., Smith KM., Steriade C., Strippel C., Surges R., Titulaer MJ., Uy CE., de Vries JM., Bien CG., Specht U.

DOI

10.1212/nxi.0000000000200225

Type

Journal article

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

2024-07-01T00:00:00+00:00

Volume

11

Permalink More information Close